SecBot SecBot
144 ·Filed Nov 5, 2026

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD
NEUTRAL
Impact 2/10
Horizondays Processed11d 7h ago SEC0001973379-26-000362
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The sale is small relative to market cap and appears to be a routine compensation-related transaction. Monitor for any additional insider selling patterns or changes in insider holdings in upcoming Form 4 filings.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$42.61
T+0 close · Nov 5, 2026 · via day close
Latest settled
+4.44%
T+5 · $44.50
Vs SPY
+1.84%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $42.61entry
  2. T+1 · 8d ago +0.84%α −1.52% · $42.97
  3. T+5 · 4d ago +4.44%α +1.84% · $44.50
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Mark Sabag, Executive VP of International Markets Commercial at Teva, filed a Form 144 notice of intent to sell 46,000 ordinary shares valued at approximately $1.93 million, based on an indicative market price of $41.93 per share. The sale is tied to a stock option exercise and compensation, representing a routine insider sale for tax or diversification purposes.

Key Facts

  • Insider: Mark Sabag, Executive VP International Markets Commercial
  • Shares to be sold: 46,000 ordinary shares
  • Approximate value: $1,928,728.30 (based on indicative price of $41.928876)
  • Broker: Citigroup Global Markets Inc.
  • Sale type: Stock option exercise and sale, compensation-related
  • Filing date: November 5, 2026
  • Company market cap: $48.8B
  • Sale value represents ~0.004% of market cap

Financial Impact

Sale of 46,000 shares worth ~$1.93M, representing about 0.004% of Teva's $48.8B market cap

dilution

Risk Factors

  • Insider sale may signal personal liquidity needs or tax planning, not necessarily a bearish view
  • Form 144 is an intent to sell; the actual sale may not occur

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001973379-26-000362
Document: 0001973379-26-000362-index.html0001973379-26-000362
Document: 0001973379-26-000362.txt0001973379-26-000362

Track record

61 reports on TEVA

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +33.06% at T+60 after the Jul 20, 2026 report. 15 of 17 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $43.16 Now $42.57 −1.37% settles Feb 12
  2. Nov 12, 20264d ago 3 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
  3. Nov 12, 20264d ago 144 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $43.65 Now $42.57 −2.47% settles Feb 10
  5. Nov 10, 20266d ago 144 Neutral 3/10 Entry $43.24 Now $42.57 −1.55% settles Feb 9
  6. Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
  7. Nov 9, 20267d ago 144 Neutral 2/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
  8. Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
  9. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
  10. Nov 5, 202611d ago 144 Neutral 2/10 Viewing Entry $42.61 Now $42.57 −0.09% settles Feb 4
Showing 10 of 61

US Market Status

Market Closed · Opens Wed (10h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026